GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » Cash Flow from Financing

Longduoduo Co (Longduoduo Co) Cash Flow from Financing : $-0.01 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2024, Longduoduo Co paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Longduoduo Co spent $0.00 Mil on financial activities for the three months ended in Mar. 2024.


Longduoduo Co Cash Flow from Financing Historical Data

The historical data trend for Longduoduo Co's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co Cash Flow from Financing Chart

Longduoduo Co Annual Data
Trend Jun21 Jun22 Jun23
Cash Flow from Financing
- 0.18 -0.14

Longduoduo Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 -0.01 - - -

Longduoduo Co Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Longduoduo Co's Cash from Financing for the fiscal year that ended in Jun. 2023 is calculated as:

Longduoduo Co's Cash from Financing for the quarter that ended in Mar. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Longduoduo Co  (OTCPK:LDDD) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Longduoduo Co's issuance of stock for the three months ended in Mar. 2024 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Longduoduo Co's repurchase of stock for the three months ended in Mar. 2024 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Longduoduo Co's net issuance of debt for the three months ended in Mar. 2024 was $0.00 Mil. Longduoduo Co received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Longduoduo Co's net issuance of preferred for the three months ended in Mar. 2024 was $0.00 Mil. Longduoduo Co paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Longduoduo Co's cash flow for dividends for the three months ended in Mar. 2024 was $0.00 Mil. Longduoduo Co received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Longduoduo Co's other financing for the three months ended in Mar. 2024 was $0.00 Mil. Longduoduo Co received $0.00 Mil on other financial activities.


Longduoduo Co Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Longduoduo Co (Longduoduo Co) Business Description

Traded in Other Exchanges
N/A
Address
Ordos Street, 419, Floor 4, Comprehensive Building, Second Light Hospital, Yuquan District, Inner Mongolia, Hohhot, CHN, 010000
Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co (Longduoduo Co) Headlines

No Headlines